| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 1,394 | 1,121 | +24.4% |
| EBITDA | 212 | 136 | +56.7% |
| EBITDA margin | 15.2% | 12.1% | +3.1 pts |
| Profit before tax | 148 | 92.9 | +59.3% |
| Net profit | 111 | 69.5 | +60.4% |
| EPS | ₹7.07 | ₹4.40 | +60.7% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 9,543 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 201 | 188 | 85.6 | 78.8 | 72.7 | ||
| 792 | 792 | 764 | 733 | 397 | ||
| 10,134 | — | — | — | — | ||
| 4,924 | 4,388 | 4,178 | 4,136 | 4,773 | ||
| — | +5.0% | +1.0% | −13.3% | — | ||
| 701 | 567 | 519 | 421 | 547 | ||
| 14.2% | 12.9% | 12.4% | 10.2% | 11.5% | ||
| 505 | 392 | 361 | 285 | 425 | ||
| 351 | 278 | 251 | 183 | 308 | ||
| 7.1% | 6.3% | 6.0% | 4.4% | 6.4% | ||
| ₹22.19 | ₹17.59 | ₹15.90 | ₹11.58 | ₹19.46 | ||
| — | +10.6% | +37.3% | −40.5% | — | ||
| — | 524 | 508 | 430 | 462 | ||
| — | −299 | −366 | −568 | −481 | ||
| 225 | 225 | 142 | −138 | −18.9 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 9,542.8 | |
| - Cash, Equiv & ST Investments | 72.7 | 78.8 | 85.6 | 188.5 | 200.7 | |
| + Total Debt | 396.7 | 733.0 | 763.8 | 791.8 | 791.8 | |
| Enterprise Value | — | — | — | — | 10,133.9 | |
| Revenue | 4,772.7 | 4,135.8 | 4,177.6 | 4,388.1 | 4,924.1 | |
| Growth %, YoY | — | -13.3 | +1.0 | +5.0 | — | |
| EBITDA | 547.1 | 421.1 | 519.1 | 567.0 | 700.7 | |
| Margin % | 11.46 | 10.18 | 12.43 | 12.92 | 14.23 | |
| EBIT | 425.0 | 285.0 | 361.5 | 391.6 | 505.3 | |
| Net Income | 307.5 | 182.9 | 251.2 | 277.9 | 350.6 | |
| Margin % | 6.44 | 4.42 | 6.01 | 6.33 | 7.12 | |
| EPS, Adj (current shares) | 19.46 | 11.58 | 15.90 | 17.59 | 22.19 | |
| Growth %, YoY | — | -40.5 | +37.3 | +10.6 | — | |
| Cash from Operations | 462.5 | 430.0 | 508.1 | 524.3 | — | |
| Capital Expenditures | -481.4 | -568.4 | -365.8 | -299.4 | — | |
| Free Cash Flow | -18.9 | -138.4 | 142.3 | 224.9 | 224.9 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Jubilant Ingrevia (NSE: JUBLINGREA) had a market capitalisation of ₹8,801 crore at the 30 October 2026 close (₹558.40 a share), a PE ratio of 25.1 on the last four quarters' profit and a price-to-book ratio of 2.65. In FY26 its consolidated net profit was ₹278 crore on revenue of ₹4,388 crore; in Q2 FY27 (July–September 2026) it was ₹111 crore, up 60.4% year on year. Its debt-to-equity ratio was 0.27 on 30 September 2026. Promoters held 45.22% of the shares on 30 September 2026.
Jubilant Ingrevia's PE ratio is 25.1 at the 30 October 2026 close (₹558.40 a share): a market capitalisation of ₹8,801 crore divided by consolidated net profit of ₹351 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹278 crore) it is 31.7.
No. Jubilant Ingrevia had borrowings of ₹895 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.27. Its cash and current investments were ₹202 crore, so its net debt was ₹693 crore.
Jubilant Ingrevia's debt-to-equity ratio was 0.27 on 30 September 2026: borrowings of ₹895 crore against total equity of ₹3,316 crore. A year earlier, on 30 September 2025, it was 0.27.
Jubilant Ingrevia's price-to-book (PB) ratio is 2.65 at the 30 October 2026 close: a market capitalisation of ₹8,801 crore divided by shareholders' equity (book value) of ₹3,316 crore on 30 September 2026. That is a book value of ₹210.42 per share against a share price of ₹558.40.
Jubilant Ingrevia's net worth — shareholders' equity in its consolidated balance sheet — was ₹3,316 crore on 30 September 2026, up 9.1% from ₹3,041 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹8,801 crore at the 30 October 2026 close.
In FY26, Jubilant Ingrevia's return on equity (ROE) was 9.2% and its return on capital employed (ROCE) was 10.4%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 8.9% and ROCE 10.2%.
Jubilant Ingrevia's market capitalisation was ₹8,801 crore at the 30 October 2026 close: 15.76 crore shares at ₹558.40 each.
Jubilant Ingrevia's basic earnings per share (EPS) were ₹17.59 in FY26, against ₹15.89 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹22.21.
Jubilant Ingrevia's dividend yield is 0.90% at the 30 October 2026 close: dividends of ₹5 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹558.40. They were ₹2.50 on 24 July 2026 and ₹2.50 on 10 February 2026 (interim).
Jubilant Ingrevia's book value per share was ₹210.42 on 30 September 2026: shareholders' equity of ₹3,316 crore divided by the 15.76 crore shares in issue, up 9.3% from ₹192.60 a year earlier. The share price at the 30 October 2026 close was ₹558.40.
In 2026, Jubilant Ingrevia has declared two dividends totalling ₹5 a share: ₹2.50 (interim) with record date 10 February 2026 and ₹2.50 with record date 24 July 2026.
In FY26 (April 2025–March 2026), Jubilant Ingrevia's consolidated net profit was ₹278 crore, up 10.6% from ₹251 crore in FY25, on revenue from operations of ₹4,388 crore (up 5.0%). Over three years, from FY23, net profit was down 9.6%.
Promoters held 45.22% of Jubilant Ingrevia on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Jubilant Ingrevia generated ₹524 crore of cash from operations and spent ₹299 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹225 crore. In FY25 it was ₹142 crore.
Jubilant Ingrevia's latest results are for Q2 FY27 (July–September 2026): consolidated net profit ₹111 crore, up 60.4% from ₹69.5 crore in Q2 FY26; revenue from operations ₹1,394 crore, up 24.4% year on year.
On 30 September 2026, Jubilant Ingrevia's shares were held by promoters 45.22%, foreign portfolio investors (FII/FPI) 6.94%, domestic institutions (DII) 25.17% (including mutual funds at 22.59%) and retail and other non-institutional investors 21.69%. Over the year, FII holding was up 0.98 percentage points from 5.96% and DII holding was up 2.13 percentage points from 23.04%.
Jubilant Ingrevia has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
At the 30 October 2026 closing prices, on FY26 net profit, Jubilant Ingrevia's PE ratio is 31.7, the second highest of the four: Vidhi Specialty Food Ingredients 31.4, Paradeep Phosphates 13.5 and PCBL Chemical 55.1, a peer average of 33.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On FY26 consolidated figures, against Vidhi Specialty Food Ingredients, Paradeep Phosphates and PCBL Chemical: Jubilant Ingrevia's operating margin of 8.9% is the second highest of the four (Vidhi Specialty Food Ingredients 18.1%, Paradeep Phosphates 8.0%, PCBL Chemical 8.2%; peer average 11.4%); its return on equity of 9.2% is the third highest of the four (Vidhi Specialty Food Ingredients 15.6%, Paradeep Phosphates 18.4%, PCBL Chemical 5.1%; peer average 13.0%); its revenue growth over three years of −2.8% a year is the lowest of the four (Vidhi Specialty Food Ingredients −2.0% a year, Paradeep Phosphates 17.8% a year, PCBL Chemical 12.4% a year; peer average 9.4% a year).
In FY26, Jubilant Ingrevia earned net profit of ₹278 crore on revenue of ₹4,388 crore, against ₹49 crore on ₹380 crore for Vidhi Specialty Food Ingredients. Jubilant Ingrevia's operating margin was 8.9% (Vidhi Specialty Food Ingredients 18.1%) and its return on equity 9.2% (Vidhi Specialty Food Ingredients 15.6%). At the 30 October 2026 close, Jubilant Ingrevia's market capitalisation was ₹8,801 crore against ₹1,538 crore for Vidhi Specialty Food Ingredients, and its PE ratio on FY26 profit 31.7 against 31.4.
From Jubilant Ingrevia's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.